GE HealthCare Technologies Inc. (NASDAQ:GEHC) Shares Acquired by First Citizens Bank & Trust Co.

First Citizens Bank & Trust Co. raised its stake in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 1.1% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 38,956 shares of the company’s stock after buying an additional 419 shares during the quarter. First Citizens Bank & Trust Co.’s holdings in GE HealthCare Technologies were worth $3,046,000 at the end of the most recent reporting period.

Other large investors have also recently bought and sold shares of the company. LGT Financial Advisors LLC lifted its stake in shares of GE HealthCare Technologies by 1,673.3% during the 3rd quarter. LGT Financial Advisors LLC now owns 266 shares of the company’s stock worth $25,000 after purchasing an additional 251 shares during the period. Ashton Thomas Securities LLC purchased a new position in GE HealthCare Technologies in the third quarter valued at about $26,000. Capital Performance Advisors LLP acquired a new stake in shares of GE HealthCare Technologies during the third quarter valued at about $26,000. Darwin Wealth Management LLC acquired a new stake in shares of GE HealthCare Technologies during the third quarter valued at about $31,000. Finally, Continuum Advisory LLC grew its stake in shares of GE HealthCare Technologies by 101.8% during the third quarter. Continuum Advisory LLC now owns 333 shares of the company’s stock valued at $31,000 after acquiring an additional 168 shares in the last quarter. Institutional investors and hedge funds own 82.06% of the company’s stock.

GE HealthCare Technologies Trading Up 0.6 %

GE HealthCare Technologies stock opened at $88.67 on Monday. The company has a 50 day moving average price of $82.32 and a 200 day moving average price of $84.78. GE HealthCare Technologies Inc. has a 52 week low of $71.42 and a 52 week high of $94.55. The company has a debt-to-equity ratio of 1.12, a quick ratio of 0.98 and a current ratio of 1.23. The firm has a market capitalization of $40.51 billion, a price-to-earnings ratio of 24.36, a P/E/G ratio of 2.88 and a beta of 1.11.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its quarterly earnings results on Wednesday, October 30th. The company reported $1.14 EPS for the quarter, beating the consensus estimate of $1.06 by $0.08. GE HealthCare Technologies had a net margin of 8.56% and a return on equity of 25.19%. The business had revenue of $4.86 billion for the quarter, compared to analysts’ expectations of $4.87 billion. During the same period in the previous year, the company posted $0.99 EPS. GE HealthCare Technologies’s revenue was up .9% on a year-over-year basis. Research analysts forecast that GE HealthCare Technologies Inc. will post 4.3 EPS for the current year.

GE HealthCare Technologies Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Stockholders of record on Tuesday, January 14th will be issued a dividend of $0.035 per share. This is a boost from GE HealthCare Technologies’s previous quarterly dividend of $0.03. This represents a $0.14 annualized dividend and a dividend yield of 0.16%. The ex-dividend date is Tuesday, January 14th. GE HealthCare Technologies’s payout ratio is currently 3.85%.

Insider Activity at GE HealthCare Technologies

In related news, CEO Roland Rott sold 3,577 shares of GE HealthCare Technologies stock in a transaction on Wednesday, November 6th. The shares were sold at an average price of $86.48, for a total value of $309,338.96. Following the completion of the sale, the chief executive officer now owns 24,298 shares of the company’s stock, valued at approximately $2,101,291.04. The trade was a 12.83 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. 0.27% of the stock is owned by company insiders.

Wall Street Analysts Forecast Growth

Several research analysts have recently commented on the company. Wells Fargo & Company lifted their target price on GE HealthCare Technologies from $95.00 to $96.00 and gave the stock an “overweight” rating in a research report on Thursday, October 31st. Evercore ISI raised their price target on shares of GE HealthCare Technologies from $98.00 to $102.00 and gave the company an “outperform” rating in a research note on Tuesday, October 1st. Jefferies Financial Group upgraded shares of GE HealthCare Technologies from a “hold” rating to a “buy” rating and raised their price target for the company from $95.00 to $103.00 in a research note on Wednesday, January 8th. Finally, Stifel Nicolaus raised their price objective on shares of GE HealthCare Technologies from $100.00 to $102.00 and gave the company a “buy” rating in a research note on Monday, September 30th. One investment analyst has rated the stock with a sell rating, four have issued a hold rating, nine have issued a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $96.00.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.